US2018319849A1PendingUtilityA1
Methods of analyzing cell membranes
Est. expiryNov 1, 2035(~9.3 yrs left)· nominal 20-yr term from priority
C12N 1/06C07K 14/215C12N 1/20
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of precipitating cell membrane fragments from a cell lysate is disclosed. The method comprises contacting the cell lysate with a hydrophobic chelator and a metal ion under conditions that allow precipitation of the cell membrane fragments. Kits for precipitating cell membrane fragments are also disclosed.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of purifying a membrane protein comprising:
(a) contacting fragments of a cell membrane which comprises the membrane protein with a hydrophobic chelator and metal ions to generate a complex which comprises said fragments of the cell membrane, said hydrophobic chelator and said metal ions; (b) isolating said cell membrane fragments following said precipitating; and (c) solubilizing said membrane protein, thereby purifying the membrane protein.
2 . The method of claim 1 , wherein said fragments have a length ranging between 200-700 nm.
3 . The method of claim 1 , wherein said solubilizing is effected using a detergent.
4 . The method of claim 3 , wherein said detergent is a non-ionic detergent.
5 . The method of claim 3 , wherein said detergent is selected from the group consisting of decyl β-D-maltoside (DM), dodecyl β-D-maltoside (DDM), octyl β-D-glucoside (OG) and octyl 62 -D-1-thioglucoside (OTG).
6 . The method of claim 1 , wherein said isolating comprises:
(a) centrifuging said cell lysate to form a pellet comprising said cell membrane fragments and a supernatant; and (b) removing said supernatant from said pellet.
7 . The method of claim 1 , wherein the membrane protein is a retinyledene protein.
8 . The method of claim 7 , wherein said retinyledene protein is selected from the group consisting of channelrhodopsin, bacteriorhodopsin, halorhodopsin, and proteorhodopsin.
9 . The method of claim 8 , wherein said retinyledene protein comprises halorhodopsin.
10 . The method of claim 9 , wherein said halorhodopsin is derived from Natronomonas pharaonis.
11 . A composition of matter comprising a N-(1,10-Phenanthrolin-5-yl)alkylamide), wherein the alkyl is from 1-9 carbon atoms in length.
12 . The composition of matter of claim 11 , wherein said N-(1,10-Phenanthrolin-5-yl)alkylamide) is selected from N-(1,10-Phenanthrolin-5-yl)methanamide) (Phen-C1), N-(1,10-Phenanthrolin-5-yl)ethanamide) (Phen-C2), N-(1,10-Phenanthrolin-5-yl)propanamide) (Phen-C3), N-(1,10-Phenanthrolin-5-yl)butanamide) (Phen-C4), N-(1,10-Phenanthrolin-5-yl)pentanamide) (Phen-C5), N-(1,10-Phenanthrolin-5-yl)hexanamide) (Phen-C6), N-(1,10-Phenanthrolin-5-yl)heptanamide) (Phen-C7), N-(1,10-Phenanthrolin-5-yl)octanamide) (Phen-C8), and N-(1,10-Phenanthrolin-5-yl)nonanamide) (Phen-C9).Join the waitlist — get patent alerts
Track US2018319849A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.